Horizon Therapeutics Public Ltd Co

ASSETMARK, INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

512

Value ($000)

53

Weight

0.0%

2019 Q4 - 2023 Q2 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	53	0.0%	512	6/30/2023
2023 Q1	5/5/2023	42	0.0%	386	3/31/2023
2022 Q4	2/10/2023	124	0.0%	1,088	12/31/2022
2022 Q3	11/1/2022	64	0.0%	1,033	9/30/2022
2022 Q2	8/3/2022	72	0.0%	902	6/30/2022
2022 Q1	5/13/2022	35	0.0%	337	3/31/2022
2021 Q1	5/14/2021	0	0.0%	2	3/31/2021
2020 Q4	2/10/2021	0	0.0%	2	12/31/2020
2020 Q3	11/13/2020	1	0.0%	13	9/30/2020
2020 Q2	8/11/2020	472	0.0%	8,495	6/30/2020
2020 Q1	5/12/2020	4,437	0.0%	149,814	3/31/2020
2019 Q4	2/11/2020	3,229	0.0%	89,189	12/31/2019